About
Contact Us
Terms of Use
Privacy Policy
Advertise

Marketing & Advertising
R&D
Therapeutics
Resources
Manny Awards
Events
Issue Archives
Subscribe
Menu

Nothing Found

Sorry, no posts matched your criteria

Recent

Structure Therapeutics surges on promising early stage obesity...September 29, 2023 - 10:15 am
Fabre-Kramer finally gets FDA approval for MDD drug after...September 29, 2023 - 9:35 am
Madrigal pursues $500M public offering with NASH market...September 29, 2023 - 9:30 am
AbbVie’s blood cancer combo therapy fails in late-stage...September 29, 2023 - 8:49 am

Popular

Structure Therapeutics surges on promising early stage obesity...September 29, 2023 - 10:15 am
OTC Review And OutlookMarch 9, 2011 - 4:17 pm
Global Contract Manufacturing Companies: Pharmaceutical...November 11, 2011 - 3:31 pm
Drug Delivery Review And OutlookDecember 11, 2011 - 3:01 pm

Tags

AbbVie acquisition Alzheimer's disease artificial intelligence AstraZeneca Biogen BioNTech Bristol-Myers Squibb cancer China clinical trial clinical trials Covid-19 COVID-19 pandemic Drug development Eli Lilly European Union FDA gene therapy GSK healthcare communications healthcare marketing Johnson & Johnson lawsuit leadership Med Ad News Merck Moderna monkeypox Novartis Novo Nordisk Oncology pandemic patient access patient safety people on the move Pfizer rare disease regulatory approval Roche Sanofi supply chain U.S. Food and Drug Administration (FDA) United States World Health Organization

© Copyright - PharmaLive and Outcomes LLC | Designed by Joe Lumi LLC

PharmaLive